Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells

Yoshifumi Kawamura(Tohoku University), Chikashi Ishioka(Tohoku University), Ken Saijo(Tohoku University), Hiroo Imai(Tohoku University)
Cancer Science
July 30, 2021
Cited by 9


Related Papers